Literature DB >> 20570112

Myeloid derived suppressor cells and their role in tolerance induction in cancer.

Taku Fujimura1, Karsten Mahnke, Alexander H Enk.   

Abstract

Myeloid derived suppressor cells (MDSCs) comprise a phenotypically heterogeneous population of cells, which can be found in tumor-bearing mice and in patients with cancer. MDSCs play a central role in the induction of peripheral tolerance. Together with regulatory T cells (Tregs) they promote an immunosuppressive environment in tumor-bearing hosts. The phenotype of MDSCs differs in humans and mice, and the exact mechanisms of their suppressive function are still controversially discussed. In summary, MDSCs are a group of phenotypically heterogeneous cells of myeloid origin that have common biological activities. In this review, we discuss the definition of MDSCs, the proposed mechanisms of expansion and the recruitment and activation of MDSCs, as well as their biological activities in tumorbearing hosts to assess the potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570112     DOI: 10.1016/j.jdermsci.2010.05.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  37 in total

1.  Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury.

Authors:  Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.

Authors:  Sheinei J Saleem; Daniel H Conrad
Journal:  Int Immunopharmacol       Date:  2011-03-21       Impact factor: 4.932

3.  Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.

Authors:  Tillmann Michels; Galina V Shurin; Hiam Naiditch; Alexandra Sevko; Viktor Umansky; Michael R Shurin
Journal:  J Immunotoxicol       Date:  2012-01-28       Impact factor: 3.000

4.  Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Minoru Toyoda; Katsumasa Takahashi; Takanori Yamamoto; Keisuke Masuyama
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

Review 5.  Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.

Authors:  Wei Pan; Qian Sun; Yang Wang; Jian Wang; Shui Cao; Xiubao Ren
Journal:  Tumour Biol       Date:  2015-04-01

Review 6.  Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.

Authors:  Amjad Ali Khan; Khaled S Allemailem; Saleh A Almatroodi; Ahmed Almatroudi; Arshad Husain Rahmani
Journal:  3 Biotech       Date:  2020-03-10       Impact factor: 2.406

7.  Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model.

Authors:  Guilan Shi; Huiru Wang; Xiufen Zhuang
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

8.  Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.

Authors:  Katarzyna Pogoda; Maria Pyszniak; Paweł Rybojad; Jacek Tabarkiewicz
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

Review 9.  Immunotherapy for solid tumors--a review for surgeons.

Authors:  Abdul Saied; Venu G Pillarisetty; Steven C Katz
Journal:  J Surg Res       Date:  2013-12-25       Impact factor: 2.192

Review 10.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.